Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+15.82%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$28.7B
AUM Growth
+$4.18B
(+17%)
Cap. Flow
-$12.2B
Cap. Flow
% of AUM
-42.5%
Top 10 Holdings %
Top 10 Hldgs %
36.41%
Holding
1,665
New
77
Increased
1,004
Reduced
446
Closed
86
Top Buys
| 1 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$69.1M |
| 2 |
iShares S&P 100 ETF
OEF
|
$58.9M |
| 3 |
iShares MBS ETF
MBB
|
$58.1M |
| 4 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
$58.1M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$34.2M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$4.12B |
| 2 |
MakeMyTrip
MMYT
|
$2.34B |
| 3 |
Trip.com Group
TCOM
|
$752M |
| 4 |
Yum China
YUMC
|
$508M |
| 5 |
Alibaba
BABA
|
$457M |
Sector Composition
| 1 | Technology | 34.56% |
| 2 | Communication Services | 9.63% |
| 3 | Consumer Discretionary | 9.36% |
| 4 | Healthcare | 6.11% |
| 5 | Financials | 5.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALMS
1476
Alumis Inc. Common Stock
ALMS
$461M
| $11.1K | ﹤0.01% |
3,692
+2,112
| +134% | +$6.34K |
|
1477
SITE Centers
SITC
$491M
| $11.1K | ﹤0.01% |
978
-297
| -23% | -$3.36K |
|
|
UHT
1478
Universal Health Realty Income Trust
UHT
$571M
| $10.9K | ﹤0.01% |
273
-82
| -23% | -$3.28K |
|
1479
Braskem
BAK
$1.38B
| $10.9K | ﹤0.01% |
3,312
+201
| +6% | +$659 |
|
|
ALX
1480
Alexander's
ALX
$1.2B
| $10.8K | ﹤0.01% |
48
-14
| -23% | -$3.16K |
|
1481
Vanda Pharmaceuticals
VNDA
$274M
| $10.7K | ﹤0.01% |
2,277
+326
| +17% | +$1.54K |
|
1482
Monte Rosa Therapeutics
GLUE
$311M
| $10.7K | ﹤0.01% |
2,376
+320
| +16% | +$1.44K |
|
|
SLN
1483
Silence Therapeutics
SLN
$263M
| $10.5K | ﹤0.01% |
1,817
+244
| +16% | +$1.42K |
|
1484
nCino
NCNO
$3.51B
| $10.4K | ﹤0.01% |
373
-9,873
| -96% | -$276K |
|
|
FPI
1485
Farmland Partners
FPI
$474M
| $10.4K | ﹤0.01% |
905
-331
| -27% | -$3.81K |
|
1486
Lemonade
LMND
$3.67B
| $10.3K | ﹤0.01% |
235
-7,151
| -97% | -$313K |
|
1487
AngloGold Ashanti
AU
$30.3B
| $10.2K | ﹤0.01% |
+224
| New | +$10.2K |
|
1488
Rocket Pharmaceuticals
RCKT
$352M
| $10.2K | ﹤0.01% |
4,162
+594
| +17% | +$1.46K |
|
1489
Annexon
ANNX
$238M
| $10.2K | ﹤0.01% |
4,238
+671
| +19% | +$1.61K |
|
1490
Alpha Teknova
TKNO
$229M
| $10.1K | ﹤0.01% |
2,064
+280
| +16% | +$1.38K |
|
1491
Foghorn Therapeutics
FHTX
$321M
| $10.1K | ﹤0.01% |
2,153
+292
| +16% | +$1.37K |
|
|
INZY
1492
DELISTED
Inozyme Pharma
INZY
| $9.98K | ﹤0.01% |
2,494
+440
| +21% | +$1.76K |
|
1493
Entrada Therapeutics
TRDA
$203M
| $9.85K | ﹤0.01% |
1,466
+208
| +17% | +$1.4K |
|
|
CMPS
1494
Compass Pathways
CMPS
$486M
| $9.84K | ﹤0.01% |
3,514
+1,501
| +75% | +$4.2K |
|
1495
First Citizens BancShares
FCNCA
$25.2B
| $9.78K | ﹤0.01% |
+5
| New | +$9.78K |
|
|
CHCT
1496
Community Healthcare Trust
CHCT
$442M
| $9.76K | ﹤0.01% |
587
-176
| -23% | -$2.93K |
|
1497
Gold Fields
GFI
$30.9B
| $9.56K | ﹤0.01% |
+404
| New | +$9.56K |
|
1498
Allogene Therapeutics
ALLO
$255M
| $9.55K | ﹤0.01% |
8,450
+1,434
| +20% | +$1.62K |
|
|
THRD
1499
DELISTED
Third Harmonic Bio
THRD
| $9.47K | ﹤0.01% |
1,743
+235
| +16% | +$1.28K |
|
|
BFS
1500
Saul Centers
BFS
$815M
| $9.42K | ﹤0.01% |
276
-83
| -23% | -$2.83K |
|